|Bid||0.1050 x 0|
|Ask||0.1100 x 0|
|Day's range||0.1000 - 0.1320|
|52-week range||0.0490 - 0.1450|
|Beta (5Y monthly)||2.67|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
ImpediMed ( ASX:IPD ) First Half 2023 Results Key Financial Results Revenue: AU$5.66m (up 8.8% from 1H 2022). Net loss...
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...
With the business potentially at an important milestone, we thought we'd take a closer look at ImpediMed Limited's...